|
| 38056546 | Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: The EARLY TAVR trial. | Am Heart J | 2024 |
| 36754512 | Impact of Transcatheter Mitral Valve Repair Availability on Volume and Outcomes of Surgical Repair. | J Am Coll Cardiol | 2023 |
| 37562540 | Transcatheter Edge-to-Edge Repair in Patients With Hypertrophic Cardiomyopathy and Severe Mitral Regurgitation After Septal Myectomy. | Can J Cardiol | 2023 |
| 37793121 | Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints. | Eur Heart J | 2023 |
| 37503662 | Association of Depression and Cognitive Dysfunction With Patient-Centered Outcomes After Transcatheter Aortic Valve Replacement. | Circ Cardiovasc Interv | 2023 |
| 37731195 | Proteomic architecture of frailty across the spectrum of cardiovascular disease. | Aging Cell | 2023 |
| 37730284 | Transcatheter Edge-to-Edge Repair in 5,000 Patients With Secondary Mitral Regurgitation: COAPT Post-Approval Study. | J Am Coll Cardiol | 2023 |
| 37345820 | Metabolic Signatures of Cardiac Dysfunction, Multimorbidity, and Post-Transcatheter Aortic Valve Implantation Death. | J Am Heart Assoc | 2023 |
| 37339188 | Target Aortic Stenosis: A National Initiative to Improve Quality of Care and Outcomes for Patients With Aortic Stenosis. | Circ Cardiovasc Qual Outcomes | 2023 |
| 37225286 | Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial. | JACC Cardiovasc Interv | 2023 |
| 36752439 | Progression Rate of Aortic Stenosis: Why Does It Matter? | JACC Cardiovasc Imaging | 2023 |
| 36813373 | Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials. | J Am Coll Cardiol | 2023 |
| 35301869 | Left Ventricular Hypertrophy and Biomarkers of Cardiac Damage and Stress in Aortic Stenosis. | J Am Heart Assoc | 2022 |
| 35471674 | A Preliminary Study on the Usage of a Data-Driven Probabilistic Approach to Predict Valve Performance Under Different Physiological Conditions. | Ann Biomed Eng | 2022 |
| 35396218 | British Societies' recommendations for Heart Team multidisciplinary meetings: broadly relevant principles with anticipated regional differences in process. | Heart | 2022 |
| 35595203 | Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement. | J Am Coll Cardiol | 2022 |
| 35656983 | Neutrophil-to-Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries. | J Am Heart Assoc | 2022 |
| 36172966 | Global Longitudinal Strain and Biomarkers of Cardiac Damage and Stress as Predictors of Outcomes After Transcatheter Aortic Valve Implantation. | J Am Heart Assoc | 2022 |
| 35895046 | Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes. | JAMA Cardiol | 2022 |
| 35951553 | What matters most to patients with severe aortic stenosis when choosing treatment? Framing the conversation for shared decision making. | PLoS One | 2022 |
| 35976635 | Association of Transcatheter Aortic Valve Replacement Reimbursement, New Technology Add-on Payment, and Procedure Volumes With Embolic Protection Device Use. | JAMA Cardiol | 2022 |
| 34920860 | Relation of Subacute Kidney Injury to Mortality After Transcatheter Aortic Valve Implantation. | Am J Cardiol | 2022 |
| 35241221 | The Alarm Blares for Undertreatment of Aortic Stenosis: How Will We Respond? | J Am Coll Cardiol | 2022 |
| 34936723 | Impact of blood pressure on coronary perfusion and valvular hemodynamics after aortic valve replacement. | Catheter Cardiovasc Interv | 2022 |
| 34048509 | Effect of a pragmatic home-based mobile health exercise intervention after transcatheter aortic valve replacement: a randomized pilot trial. | Eur Heart J Digit Health | 2021 |
| 33844581 | Unloading the Stenotic Path to Identifying Medical Therapy for Calcific Aortic Valve Disease: Barriers and Opportunities. | Circulation | 2021 |
| 34857095 | Evaluating Medical Therapy for Calcific Aortic Stenosis: JACC State-of-the-Art Review. | J Am Coll Cardiol | 2021 |
| 35024506 | The CNP/NPR-B/cGMP Axis is a Therapeutic Target in Calcific Aortic Stenosis. | JACC Basic Transl Sci | 2021 |
| 34555446 | Racial, ethnic and socioeconomic disparities in patients undergoing transcatheter mitral edge-to-edge repair. | Int J Cardiol | 2021 |
| 34160565 | Prevention and Mitigation of Heart Failure in the Treatment of Calcific Aortic Stenosis: A Unifying Therapeutic Principle. | JAMA Cardiol | 2021 |
| 34266311 | Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial. | Circ Cardiovasc Interv | 2021 |
| 34340660 | Baseline pro-inflammatory gene expression in whole blood is related to adverse long-term outcomes after transcatheter aortic valve replacement: a case control study. | BMC Cardiovasc Disord | 2021 |
| 31202751 | Management of Asymptomatic Severe Aortic Stenosis: Evolving Concepts in Timing of Valve Replacement. | JACC Cardiovasc Imaging | 2020 |
| 34396289 | Cancer and TAVR: Reassuring Data, But Individualized and Shared Decision-Making Still Required. | JACC CardioOncol | 2020 |
| 31995118 | Incorporating the Patient Voice Into Shared Decision-Making for the Treatment of Aortic Stenosis. | JAMA Cardiol | 2020 |
| 31711153 | Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries. | Eur Heart J | 2020 |
| 31883339 | Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry. | Eur Heart J | 2020 |
| 33087585 | Caval Valve Implantation for Tricuspid Regurgitation: Insights From the United States Caval Valve Registry. | J Invasive Cardiol | 2020 |
| 32856530 | Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement. | J Am Heart Assoc | 2020 |
| 32674676 | Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and Registry. | Circ Cardiovasc Interv | 2020 |
| 33011139 | Clip It, Cut It, and Then Replace It: ELASTA-Clip for Failed MitraClip. | JACC Cardiovasc Interv | 2020 |
| 32667623 | Association of Natriuretic Peptide Levels After Transcatheter Aortic Valve Replacement With Subsequent Clinical Outcomes. | JAMA Cardiol | 2020 |
| 32418454 | Uncovering the Phenotypic Heterogeneity of Patients With Aortic Stenosis: A Path to New Insights? | Circ Cardiovasc Imaging | 2020 |
| 32499024 | Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries. | JACC Cardiovasc Interv | 2020 |
| 32408979 | Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries. | J Am Coll Cardiol | 2020 |
| 32326818 | Priorities for Patient-Centered Research in Valvular Heart Disease: A Report From the National Heart, Lung, and Blood Institute Working Group. | J Am Heart Assoc | 2020 |
| 32484159 | Managing Severe Aortic Stenosis in the COVID-19 Era. | JACC Cardiovasc Interv | 2020 |
| 30553688 | Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial Subanalysis. | JACC Cardiovasc Imaging | 2019 |
| 31642866 | Association of Cardiac Rehabilitation With Decreased Hospitalization and Mortality Risk After Cardiac Valve Surgery. | JAMA Cardiol | 2019 |
| 31665959 | Lower Blood Pressure After Transcatheter or Surgical Aortic Valve Replacement is Associated with Increased Mortality. | J Am Heart Assoc | 2019 |